Research progress of liraglutide in prevention and treatment of diabetic cardiomyopathy
The incidence of diabetic cardiomyopathy(DCM)is increasing year by year,which has attracted people's attention.Liraglutide is a hypoglycemic drug and also has the effect of protecting myocardium.Based on this,from the perspective of the pathogenesis of DCM,this article focuses on the therapeutic effect of liraglutide on DCM,and provides researchers in related fields with the latest progress of liraglutide in the treatment of DCM.
万方数据
维普
